While mTOR has been reported to associate with the IKK complex to stimulate NF-κB in prostate cancer cells[35], to our knowledge mTOR has not been demonstrated to be a driver of NF-κB activity in DLBCL. This evidence concerns the gene MTOR and prostate carcinoma.